Article

Antibody neutralization to SARS-CoV-2 and variants after one year in Wuhan

2021-06-21

Abstract excerpt

Most COVID-19 patients can build effective humoral immunity against SARS-CoV-2 after recovery( 1, 2 ). However, it remains unknown how long the protection can maintain and how efficiently it can protect people from the reinfection of the emerging SARS-CoV-2 variants. Here we evaluated the sera from 248 COVID-19 convalescents around one year post-infection in Wuhan, the earliest epicenter of SARS-CoV-2. We demonstr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 08224b17-ebfc-5040-b6bf-262e852d3274
DOI: 10.1101/2021.06.16.21258673

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Antibody neutralization to SARS-CoV-2 and variants after one year in WuhanDOI 10.1101/2021.06.16.21258673Read

Variants of SARS-CoV-2, their effects on infection, transmission and neutralization by vaccine-induced antibodies.Semantic proximity Read

Inactivated vaccine fueled adaptive immune responses to Omicron in 2-year COVID-19 convalescentsSemantic proximity Read

Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine EfficacySemantic proximity Read

Inactivated vaccine fueled adaptive immune responses to Omicron in 2-year COVID-19 convalescentsSemantic proximity Read

SARS CoV-2 escape variants exhibit differential infectivity and neutralization sensitivity to convalescent or post-vaccination seraSemantic proximity Read

Previously infected vaccinees broadly neutralize SARS-CoV-2 variantsSemantic proximity Read

Vaccine efficacy in mutant SARS-CoV-2 variants.Semantic proximity Read

Naturally enhanced neutralizing breadth to SARS-CoV-2 after one yearSemantic proximity Read

Changes of Humoral Immunity Response in SARS-CoV-2 Convalescent Patients over 8 monthsSemantic proximity Read

COVID-19 Serum Drives Spike-Mediated SARS-CoV-2 Variation.Semantic proximity Read

Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccinationSemantic proximity Read

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines.Semantic proximity Read